Albemarle (NYSE:ALB – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both materials companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.
Analyst Recommendations
This is a summary of current recommendations for Albemarle and ASP Isotopes, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Albemarle | 2 | 9 | 15 | 0 | 2.50 |
| ASP Isotopes | 1 | 0 | 2 | 0 | 2.33 |
Albemarle presently has a consensus price target of $190.04, suggesting a potential upside of 65.11%. ASP Isotopes has a consensus price target of $13.00, suggesting a potential upside of 301.23%. Given ASP Isotopes’ higher possible upside, analysts clearly believe ASP Isotopes is more favorable than Albemarle.
Volatility and Risk
Insider & Institutional Ownership
92.9% of Albemarle shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Albemarle and ASP Isotopes”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Albemarle | $5.91 billion | 2.30 | -$510.63 million | $0.27 | 426.31 |
| ASP Isotopes | $23.85 million | 20.83 | -$175.09 million | ($1.32) | -2.45 |
ASP Isotopes has lower revenue, but higher earnings than Albemarle. ASP Isotopes is trading at a lower price-to-earnings ratio than Albemarle, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Albemarle and ASP Isotopes’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Albemarle | 3.09% | 10.96% | 5.39% |
| ASP Isotopes | -427.98% | -64.99% | -32.20% |
Summary
Albemarle beats ASP Isotopes on 9 of the 14 factors compared between the two stocks.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
